TPVG logo

TriplePoint Venture Growth BDC Corp. Stock Price

NYSE:TPVG Community·US$268.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author

TPVG Share Price Performance

US$6.64
-1.57 (-19.12%)
US$6.64
-1.57 (-19.12%)
Price US$6.64

TPVG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with slight risk.

4 Risks
2 Rewards

TriplePoint Venture Growth BDC Corp. Key Details

US$93.6m

Revenue

US$0

Cost of Revenue

US$93.6m

Gross Profit

US$59.7m

Other Expenses

US$33.9m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.84
100.00%
36.22%
132.0%
View Full Analysis

About TPVG

Founded
2013
Employees
n/a
CEO
James Labe
WebsiteView website
www.tpvg.com

TriplePoint Venture Growth BDC Corp. is a business development company specializing investments in venture capital-backed companies at the growth stage investments. It also provides debt financing to venture growth space companies which includes growth capital loans, secured and customized loans, equipment financings, revolving loans and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It targeted returns between 10% and 18%. It does not take board seat in the company.

Recent TPVG News & Updates

Recent updates

No updates